Nuclear Medicine Market Size, Share will grow at a 13.2% by 2032
Research Reports
Sep 11, 2023
Nuclear Medicine Market Research Report Information By Product Type ( Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals [ Tc-99m, TI-201, Ga-67, I-123, and Others], Pet Radiopharmaceuticals [Tc-99m, TI-201, Ga-67, I-123, and Others]), Therapeutic Nuclear Medicine (Alpha Emitters[ Ra-223], Beta Emitters[I-131, Y-90, Sm-153, Lu-177, Re-186, and Others]), Brachytherapy Isoptopes [Ir-192, I-125, Pd-103, Cs-131, and Others]), By Application (Diagnostic Applications SPECT Applications[Cardiology, Neurology, Lymphoma, Thyroid, and Others]
Nuclear Medicine Market Size was valued at USD 6.24 billion in 2021 and is projected to grow from USD 7.06 billion in 2022 to USD 24.03 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 13.2% during the forecast period (2023 – 2032).
The growing incidence of target illnesses such as cardiovascular disease and cancer is propelling the nuclear medicine sector forward. The older population, which is rapidly growing, is poised to contribute to the rise in chronic illness incidence. Forecasters expect that the growing preference for employing radiopharmaceuticals to treat the elderly will result in a significant increase in the demand for nuclear medications in the near future. It is predicted to rise steadily in the next years as a consequence of increased usage, discoveries, and other reasons. However, the expensive expense of radiopharmaceuticals, as well as the negative consequences associated with radioactive contamination, continues to remain hurdles to their widespread usage.
Get Free Sample PDF Brochure @
https://www.marketresearchfuture.com/sample_request/6674
This research includes an overview of the worldwide nuclear medicine market and its strengths. The research also includes a summary of dynamics, segmentation, main players, geographical analysis, and other important elements. The research also includes a full analysis of the nuclear medicine market prediction for 2032. Coronavirus disease 2019 is an acute respiratory infection sickness caused by SARS coronavirus. COVID-19 has gone from a localized disaster to a previously unknown global epidemic in just a few weeks. In line with clinical preparation measures, scientific research operations at academic medical centers and schools were rushed to a standstill in order to limit the spread of sickness to research staff and individuals with whom they potentially come into contact.
Market Segmentation:
By application: The market is segmented into Thyroid, Cardiology, Oncology, Neurology, and Others are the application subcategories.
By end-users: The market is divided into Alpha-emitters, SPECT, PET, Beta-emitters, and Brachytherapy are the market segments.
Key Players
Cardinal Health, Lantheus Medical Imaging, Nordion Inc., Bayer, Advanced Accelerators Applications, Mallinckrodt Pharmaceuticals, GE Healthcare, Jubliant Lifesciences, and Medtronic plc, Bracco Imaging, Curium, are some of the prominent competitors in the nuclear medicine industry. Curium has acquired MAP Medical, allowing the firm to extend its position in Europe by gaining direct access to the Nordic and Baltic countries.
Regional Analysis:
North America, Europe, Asia Pacific, and the Rest of the World comprise the Global Nuclear Medicine Market. North America has the most established nuclear medicine market. Canada is the major Tc-99m producer in North America, whereas the United States is the region’s primary client market for radioisotopes. The United States was the greatest donor to the North American region in terms of income. Its dominance is expected to be challenged by rising system volume and increased use of nuclear medicine for a range of therapeutic applications. The global nuclear medicine market share is characterized by fierce competition among its competitors. However, this rivalry is caused by causes other than competitive pricing or product difference. Aside from that, significant companies in the biotechnology and pharmaceutical industries are entering this field with enormous financial reserves, increasing competitiveness even further.
Browse In-depth Market Research Report (100 Pages) on Nuclear Medicine:
https://www.marketresearchfuture.com/reports/nuclear-medicine-market-6674
Discover More Research Reports on Healthcare Industry by Market Research Future:
Lung Cancer Therapeutics Market Research Report Information By Type (SCLC and NSCLC), By Treatment (Surgery, Chemotherapy, Radiotherapy, Photodynamic Therapy (PDT) and Laser Therapy), By End-User (Hospital & Clinics and Cancer Research Centers and Laboratories), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Forecast Till 2030
Breast Cancer Market Research Report Information By Types (Invasive Ductal Carcinoma, Invasive Lobular Carcinoma), By Treatment (Chemotherapy, Surgery & Radiation Therapy, Targeted Therapy, Biologic Therapy, Hormone Therapy) By End Users (Hospital Pharmacies, Private Pharmacies), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032.
Active Pharmaceutical Ingredients Market Research Report Information By Manufacturing Process (Captive Manufacturing and Contract Manufacturing), By Type of Synthesis (Synthetic and Biotech), By API Formulation (Generic API and Branded/Innovative API), By Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology, and others), By Molecules (Large Molecule and Small Molecule), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Follow Us: LinkedIn | Twitter
Contact Information:
Contact: Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: sales@marketresearchfuture.com Website: https://www.marketresearchfuture.com
Tags:
Research Newswire, English